A Phase I Study of TACI-antibody Fusion Protein Injection (RC18) in Healthy Adult Chinese Subjects
Clinical trial NCT04235933 · COMPLETED
Trial details
- NCT number
- NCT04235933
- Sponsor
- RemeGen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-17
- Primary completion
- 2019-12-20
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.